BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 4959675)

  • 21. [Treatment of therapy-resistant child epileptics with Mogadan].
    Sörensen N; Dreyer R
    Med Welt; 1970 Aug; 33():1407-10. PubMed ID: 4996293
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of epilepsy in children using dipropyl acetic acid (DPA)].
    Ritz A; Jacobi G
    Fortschr Med; 1973 May; 91(13):590-1 passim. PubMed ID: 4633749
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of clonazepam as an anticonvulsant--clinical evaluation.
    Bladin PF
    Med J Aust; 1973 Apr; 1(14):683-8. PubMed ID: 4633863
    [No Abstract]   [Full Text] [Related]  

  • 24. [Indications for Tegretol in the treatment of epilepsy].
    Haas R; Laubichler W
    Wien Med Wochenschr; 1967 Apr; 117(14):357-61. PubMed ID: 4969501
    [No Abstract]   [Full Text] [Related]  

  • 25. [Primary generalized epilepsy in childhood. Clinico-statistical study].
    Borgheresi S; Luti E; Mecherini L; Buti Cossi D; Bardini MR
    Minerva Pediatr; 1979 Nov; 31(22):1601-4. PubMed ID: 122150
    [No Abstract]   [Full Text] [Related]  

  • 26. [Usefulness of Ospolot in the treatment of epilepsy].
    Bittner-Manicka M; Wasilewski R
    Neurol Neurochir Pol; 1971; 5(3):351-6. PubMed ID: 4398975
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possibilities and limits of clonazepam therapy in childhood].
    Rett A
    Wien Klin Wochenschr; 1971 Oct; 83(41):725-34. PubMed ID: 5000961
    [No Abstract]   [Full Text] [Related]  

  • 28. Classification and treatment of seizure disorders in children.
    Hooshmand H; Suter CG
    Va Med Mon (1918); 1970 Feb; 97(2):104-16. PubMed ID: 4367825
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug treatment of convulsive disorders.
    Millichap JG
    N Engl J Med; 1972 Mar; 286(9):464-9. PubMed ID: 4333276
    [No Abstract]   [Full Text] [Related]  

  • 30. [New methods of seizure treatment in epilepsy].
    Tchicaloff M
    Munch Med Wochenschr; 1965 Nov; 107(45):2249-52. PubMed ID: 4957660
    [No Abstract]   [Full Text] [Related]  

  • 31. [Performance and behavior disorders in childhood epilepsy].
    Freudenberg D
    Bibl Psychiatr Neurol; 1968; 135():1-116. PubMed ID: 4967991
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic effect of tegretol, a new antiepileptic agent, on epileptic seizures and emotional disorders of epileptics].
    Sonoda T; Goto Y; Taen S
    No To Shinkei; 1965 Nov; 17(11):1161-8. PubMed ID: 4957231
    [No Abstract]   [Full Text] [Related]  

  • 33. Withdrawal of barbiturate anticonvulsant drugs: prospective controlled study.
    Coulter DL
    Am J Ment Retard; 1988 Nov; 93(3):320-7. PubMed ID: 3147687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dipropylacetate (Dépakine, Ergenyl) in the treatment of epilepsy.
    Völzke E; Doose H
    Epilepsia; 1973 Jun; 14(2):185-93. PubMed ID: 4198316
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurological disease in an English city.
    Brewis M; Poskanzer DC; Rolland C; Miller H
    Acta Neurol Scand; 1966; 42():Suppl 24:1-89. PubMed ID: 4224973
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cerebral seizures (conclusion). 4. Therapy].
    Weinmann HM
    Fortschr Med; 1971 Sep; 89(25):965-70. PubMed ID: 5005210
    [No Abstract]   [Full Text] [Related]  

  • 37. The medical treatment of epilepsy: initiation of drug therapy.
    Livingston S; Pruce I; Pauli LL
    Pediatr Ann; 1979 Apr; 8(4):213-31. PubMed ID: 223107
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pyknoleptic petit mal and secondary grand mal].
    Doose H; Schwartz I
    Nervenarzt; 1976 May; 47(5):333-7. PubMed ID: 818572
    [No Abstract]   [Full Text] [Related]  

  • 39. [Relapse prognosis following reduction of drugs in epilepsy treatment].
    Janz D; Kern A; Mössinger HJ; Puhlmann U
    Nervenarzt; 1983 Oct; 54(10):525-9. PubMed ID: 6417551
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical evaluation of 2-(beta-pyridyl-(2")-ethenyl)-3-(2'-methylphenyl)-quinazolinone-(4) (B169) in the treatment of epilepsy].
    Seki T; Fukuyama Y
    No To Shinkei; 1971 Sep; 23(9):1087-92. PubMed ID: 4999247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.